Clinical Trial Update: Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This Phase I/II trial evaluated MK-0752 followed by docetaxel in advanced or metastatic breast cancer and is reported as completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• MK-0752

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-04